Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis
NCT00854087Phase 2Completed
- Start
- Aug 2010
- Primary completion
- Apr 2013
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatic fibrosis comparing Fuzheng Huayu with Placebo (2 arms). Primary endpoints: Safety of Fuzheng Huayu Treatment at Week 60 and Efficacy of Fuzheng Huayu Treatment in Improving Liver Fibrosis at Week 48. Started Aug 2010; status: completed.
02
Drugs
fuzheng huayu
03
Conditions
hepatic fibrosis
Beyond the preview
Go deeper on NCT00854087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854087.